MADRID, Feb. 11, 2026 — ArisGlobal, an AI-first technology leader in Life Sciences and the creator of LifeSphere®, has introduced five major new products designed to advance the cross-functional implementation of AI. During the opening day of its yearly conference, Breakthrough 2026, the company launched XDI, its advanced data intelligence core, three novel AI agents, and NavaX Translation for pharmacovigilance case intake processes.

XDI – Explainable AI and evidential alignment beyond functional boundaries

XDI serves as ArisGlobal’s cutting-edge data intelligence framework, capable of pulling information from diverse functions and systems to support uniform, understandable decision-making throughout pharmaceutical R&D. Rather than just speeding up tasks in isolated workflows, XDI establishes an agnostic base that harmonizes meaning, context, and purpose. This guarantees that choices made in Safety, Regulatory, Clinical, Quality, Manufacturing, and other areas are based on common understanding, consistent evidence, and standardized oversight. This approach encourages assured AI integration and use, while minimizing risk and variations in interpretation among different teams and applications.

New agents for Regulatory Intelligence, Change Distribution, and Signals

The company has also broadened its NavaX Agents Suite with three robust new agents:

• The Regulatory Intelligence Agent enhances submission quality by automatically analyzing regulatory rules, turning them into exact checklist criteria, and evaluating LifeSphere Submissions dossiers with transparent compliance ratings, explanations, and reliability scores.
• The Change Distribution Agent provides ongoing compliance verification by automatically processing updated regulations, checking them against company distribution rules, and initiating controlled change processes when inconsistencies are found.
• The Signals Agent acts as a smart helper that understands user goals, identifies the optimal analysis method, and flexibly designs and runs workflows. Functioning as an engaged intelligence collaborator, it utilizes a logic-driven coordination layer that connects safety, data, analytics, and specialist knowledge.

NavaX Translation – Transforming global case data intake workflows

Through a strategic alliance with TransPerfect, ArisGlobal now offers accredited translation services built directly into case data intake workflows. Smart language identification immediately directs non-English safety reports for processing, employing pharmaceutical-focused language models and skilled translators. The smooth API connection sends the translated documents back into LifeSphere, removing manual work and significantly speeding up worldwide drug safety monitoring. Integrating NavaX with TransPerfect slashes the time needed for translation management from approximately five hours per case to less than sixty seconds—offering exceptional automation, velocity, and precision in the industry.

“The key hurdle for life sciences is not merely embracing AI, but effectively deploying it across operations with uniformity, control, and tangible business value. These newest product upgrades further help companies transition from pilot projects to full-scale implementation, making AI a dependable pillar for organizational choices,” stated Aman Wasan, ArisGlobal’s CEO.

“We are observing a radical change in how technology strengthens life sciences groups. These advancements mark a progression from automating separate duties to coordinating intelligence throughout complete operational networks, which fosters more informed decisions, quicker understanding, and genuinely expandable AI utilization,” noted Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal.

Breakthrough 2026, taking place in Madrid, Spain, convenes senior executives, sector pioneers, and specialists to delve into the topic of “Operationalizing AI,” demonstrating how established AI applications are becoming standard procedure in life sciences.

To learn more, go to www.arisglobal.com or connect with ArisGlobal on LinkedIn.

About ArisGlobal

ArisGlobal is a premier life sciences technology firm and a supplier of cloud software for pharmacovigilance, regulatory affairs, quality management, and medical affairs. Its integrated platform, LifeSphere®, blends deep industry knowledge, sophisticated technology, and analytics to assist life sciences companies in turning compliance into a competitive edge. ArisGlobal supports over 300 clients worldwide, including numerous leading pharmaceutical, biotechnology, and medical device corporations. Additional details are available at www.arisglobal.com.

Logo – http://rssdatabase.tickerwit.com/images/601/105601_2.jpg